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This result allowed us to conclude that
arsenite-induced apoptosis of this cell
line was through the activation of caspase-3, although it remains unclear
what reaction component(s) were modified by boiling. The mechanism of
increasing sensitivity by the boiling
method needs to be studied further.

Maintaining GFP Tissue
Fluorescence through
Bone Decalcification and
Long-Term Storage
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Decalcification of bone is required
for frozen or standard histological sectioning; however, acidic decalcification
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addition, long-term storage of fluorescing tissues from in vivo studies necessitates maintaining GFP fluorescence in
a solution that does not compromise
tissue and cellular integrity.
The spread of metastatic cancer to
skeletal sites is a grim complication frequent in breast, prostate, and lung cancers. In particular, the incidence of
breast cancer metastasis to bone has
been estimated to be as high as 85% (2),
causing osteolytic lesions that result in
pathological fractures, spinal cord compression, and hypercalcemia. Why
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Figure 1. Fluorescence of GFP-tagged breast cancer metastases is maintained through decalcification and frozen sectioning of murine hind limb bones. (A) Fluorescence microscopy of whole femur and
proximal tibia following 4% paraformaldehyde fixation. Bar = 1 mm. (B) Fluorescence following 14 h incubation in 0.5 M EDTA in CMF-PBS, immediately preceding frozen sectioning. (C and E) Bright-field
photomicrographs of frozen sections. Tumor (T) has filled medullary canal but has not crossed the epiphyseal growth plate (P) into distal normal marrow (M). Since the epiphyseal growth plate is normal murine
tissue, it does not fluoresce. Normal murine tissue also exists between tumor cells, and some spaces are the
result of tissue sectioning artifact. (C, Bar = 1 mm; E, Bar = 0.1 mm). (D and F) Corresponding fluorescence microscopy reveals fluorescing tumor tissue replacing marrow of the medullary canal.
BioTechniques 1197
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breast cancer exhibits significant
predilection for bone is unknown. To
model skeletal metastasis in vivo, we
engineered metastatic human breast
carcinoma cell lines (MDA-MB-435
and MDA-MB-231) to constitutively
express GFP (4). Intracardiac injection
of cells into the left ventricle of female
athymic mice produces widespread
skeletal metastases, localized predominantly to the trabecular regions of bones
including femur, proximal tibia, proximal humerus, and lumbar vertebrae.
The utility of GFP-tagging for the
detection of metastases and tracking of
single cells in vivo has been clearly
demonstrated in several models (3,5,7)
including bone metastasis (6,8–11).
Bone metastases may be easily identified in whole bone without laborious
sectioning or radiographic detection
that customarily requires degradation
of at least 50% of the mineralized bone
(1). However, histological sectioning is
required to determine the position of
metastases at the microscopic level.
Paraffin or frozen sectioning of bone
without fixation and decalcification often causes shattering of the calcified
tissue and contributes to significant
wear or chipping of blades. While 4%
paraformaldehyde fixation of GFP tissues maintains fluorescence, decalcification methods employing acidic solutions quickly abrogate fluorescence.
Metastatic MDA-MB-435 cells
were transfected with pEGFP-N1 (BD
Biosciences Clontech, Palo Alto, CA,
USA) by electroporation (GenePulser, Bio-Rad, Laboratories, Hercules, CA, USA; 220 V, 960 µFd, ∞Ω).
The brightest 25% of the neomycin-resistant fluorescing cells were sorted using a Coulter EPICS V cell sorter
(Beckman Coulter, Fullerton, CA,
USA). Cells were introduced into
athymic mice by either mammary fat
pad or intracardiac injection. Fresh primary tumors fluoresced and continued
to fluoresce following fixation in freshly prepared 4% paraformaldehyde
(4°C) for 24–48 h. Tissues were examined using a Leica MZFLIII dissection
microscope, equipped with GFP2 filter
set (Leica, Deerfield, IL, USA). Samples were subsequently exposed to
common decalcification solutions including CalEX® (Fisher Scientific,
Pittsburgh, PA, USA), 10% sodium cit1198 BioTechniques

rate/22.5% formic acid, and 0.5 M
EDTA in calcium and magnesium-free
Dulbecco’s PBS (CMF-PBS) (pH 7.8,
4°C). While fluorescence was eliminated following incubation in the acidic
solutions (CalEX and sodium citrate/
formic acid), 0.5 M EDTA maintained
tissue fluorescence (Figure 1, A and B).
Next, to determine the minimum incubation time sufficient for decalcification, two hind limbs, dissected free of
soft tissue, were incubated in 10 mL 0.5
M EDTA (4°C) and removed at various
time points including 6, 12, 18, 24, 36
and 48 h. Bones were then mounted in
O.C.T. compound (Tissue-Tek, Elkhart,
IN, USA) and frozen-sectioned. Bones
decalcified for 18 h contained limited
calcified deposits, as determined by
blade sound and feel during frozen sectioning, while 24-h treatment achieved
complete decalcification and eliminated blade wear. Fluorescing skeletal
metastases were readily visible in
frozen sections by fluorescence microscopy (Figure 1, C–F).
Historically, extended archiving of
fluorescently tagged tissues, including

GFP-labeled cells, has also been problematic. Freezing of tissues may protect
fluorescence but can introduce freezing
artifacts. While 4% paraformaldehyde
maintains fluorescence during fixation,
long incubations can deteriorate fluorescence, as can extended storage in 70%
ethanol following fixation. Nevertheless,
retention of paraformaldehyde-fixed tissues (24-h fixation) in only CMF-PBS
(4°C) is incapable of preventing tissue
autolysis and cellular degradation. Having observed that tissue still fluoresced
after several weeks in 0.5 M EDTA at
4°C and that no tissue autolysis was apparent, we tested whether this was a possible long-term storage medium. We
have also tested two dilute solutions of
paraformaldehyde (0.5% and 1% paraformaldehyde in CMF-PBS) in parallel
with 4% paraformaldehyde. Whole murine bones (including skull, mandible,
ribcage, vertebral column, pelvis, and
limbs) were dissected free of soft tissues,
and all bones derived from an individual
mouse were combined in a single 25-mL
vial. Vials were filled with 4% paraformaldehyde (approximately 18 mL) for

Figure 2. Storage of fluorescent tissues in 0.5 M EDTA or 1% paraformaldehyde solutions maintains both tissue fluorescence and morphology. (A and B) Two brain metastases visible in a sagittal
section of the skull at two months (A) and 11 months (B). Photomicrographs with identical exposure settings were collected using a MagnaFire digital camera (Optronics, Goleta, CA, USA), and ImagePro
Plus software (Media Cybernetics, Silver Spring, MD, USA). (C and D) While there is an overall decrease in tumor cell fluorescence and a slight increase in background autofluorescence, GFP-tagged cells
are still apparent. Two vertebral metastases stored for 11 months (D, 10-s exposure) compared to an image captured of the specimen when fresh and unfixed (C, 5-s exposure). (E–G) Bright-field (E) and fluorescence (F) images of proximal humerus immediately before histological sectioning at 11 months (G).
H&E staining shows tumor (T) infiltrating through normal marrow (M) and trabecular bone (B) toward
the epiphyseal growth plate (P). (H) Metastasis in proximal right femur fluoresces following 19 months
in 1% paraformaldehyde. Bars = 1 mm.
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Benchmarks
24–48 h, and the solution was then replaced with 0.5 M EDTA, 0.5%
paraformaldehyde, or 1% paraformaldehyde, each in CMF-PBS. Vials were
stored at 4°C at all times. We can report
that 11 months storage in 0.5 M ETDA,
and 19 months in 0.5% and 1% paraformaldehyde, both soft-tissue and skeletal metastases still fluoresce (Figure 2, A
and B). Under these conditions, a few
metastases lost considerable fluorescence
and were only slightly visible above
background. By contrast, the majority of
samples stored concurrently in 4%
paraformaldehyde no longer fluoresced.
Background auto-fluorescence commonly increases following fixation, and
the intensity of GFP fluorescence is
sometimes reduced compared to fresh
tissue (Figure 2, C and D). Nonetheless, maintenance of fluorescence,
along with relatively good preservation
of cell morphology when tissues are
routinely sectioned, renders this inconvenience acceptable for most uses (Figure 2, E–G). This technique now provides investigators adequate time to
thoroughly examine tissues in largescale experiments involving several
replicates in multiple experimental
groups. The safety of 0.5 M EDTA for
both decalcification and storage also
eliminates the need for additional solution changes and enables immediate
histological processing of archived
samples, including use for standard histological staining.
In conclusion, 0.5 M EDTA in CMFPBS is capable of decalcifying murine
bones in at least 24 h without harming
GFP fluorescence and can be utilized
for long-term archival of fluorescent
specimens. Additionally, extended storage in 0.5%–1% paraformaldehyde
maintains tissue fluorescence without
concomitant decalcification.

MB-435 human breast carcinoma metastasis to
bone. Clin. Exp. Metastasis (In Press.)
5.Hoffman, R.M. 2001. Visualization of GFP-expressing tumors and metastasis in vivo.
BioTechniques 30:1016.
6.Li, Y., M. Tondravi, J. Liu, E. Smith, C.C.
Haudenschild, M. Kaczmarek, and X. Zhan.
2001. Cortactin potentiates bone metastasis of
breast cancer cells. Cancer Res. 61:6906-6911.
7.Naumov, G.N., S.M. Wilson, I.C. MacDonald,
E.E. Schmidt, V.L. Morris, A.C. Groom,
R.M. Hoffman, and A.F. Chambers. 1999.
Cellular expression of green fluorescent protein,
coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis.
J. Cell Sci. 112(Pt 12):1835-1842.
8.Peyruchaud, O., B. Winding, I. Pecheur,
C.M. Serre, P. Delmas, and P.Clezardin.
2001. Early detection of bone metastases in a
murine model using fluorescent human breast
cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of
osteolytic lesions. J. Bone Miner. Res. 16:20272034.
9.Yang, M., S. Hasegawa, P. Jiang, X. Wang, Y.
Tan, T. Chishima, H. Shimada, A.R. Moossa,
and R.M. Hoffman. 1998. Widespread skeletal
metastatic potential of human lung cancer revealed by green fluorescent protein expression.
Cancer Res. 58:4217-4221.
10.Yang, M., P. Jiang, Z. An, E. Baranov, L. Li,
S. Hasegawa, M. Al Tuwaijri, T. Chishima, et
al. 1999. Genetically fluorescent melanoma
bone and organ metastasis models. Clin. Cancer
Res. 5:3549-3559.
11.Yang, M., P. Jiang, F.X. Sun, S. Hasegawa, E.
Baranov, T. Chishima, H. Shimada, A.R.
Moossa, and R.M. Hoffman. 1999. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res. 59:781-786.

This research was supported by grants
from the National Institutes of Health
(CA87728) and the Penn State-National
Foundation for Cancer Research Center for
Metastasis Research. We are indebted to Dr.
Janet E. Price (University of Texas-M.D.
Anderson Cancer Center) for providing the
MDA-MB-435 cells. Address correspondence to Dr. Danny R. Welch, Dept. of
Pathology, University of Alabama at Birmingham, 1670 University Blvd., Birmingham, AL 35294-0019, USA. e-mail:
dwelch@path.uab.edu

REFERENCES
1.Averbuch, S.D. 1993. New bisphosphonates in
the treatment of bone metastases. Cancer
72:3443-3452.
2.Body, J.J. 1992. Metastatic bone disease:
clinical and therapeutic aspects. Bone
13(Suppl1):S57-S62.
3.Goldberg, S.F., J.F. Harms, K. Quon, and
D.R. Welch. 1999. Metastasis-suppressed
C8161 melanoma cells arrest in lung but fail to
proliferate. Clin. Exp. Metastasis 17:601-607.
4.Harms, J.F. and D.R. Welch. Human MDA-

1200 BioTechniques

Received 21 August 2002; accepted 17
September 2002.

John F. Harms, Lynn R. Budgeon, Neil D. Christensen, and
Danny R. Welch
Pennsylvania State University
College of Medicine
Hershey, PA, USA

Vital Stain to Study Cell
Invasion in Modified
Boyden Chamber Assay
BioTechniques 33:1200-1204 (December 2002)

The capacity of cancer cells to invade
basement membrane is a hallmark of
metastasis. The modified Boyden chamber assay is often used to analyze and
quantify the migratory and invasive potential of cells (5,8). It has a microporous membrane, which separates the
two chambers, and is coated with Matrigel (BD Biosciences, San Jose, CA,
USA) or any other extracellular matrix
proteins like fibronectin, laminin, or collagen. Invasive cells seeded in the upper
chamber respond to the chemoattractant
in the lower chamber, invade the gel, and
migrate to the lower surface of the membrane, whereas noninvasive cells remain
in the upper chamber. The chambers are
fixed, and cells on the upper side of the
filter are removed with a cotton swab.
Cells that have migrated to the lower
side of the filter are stained [e.g., Diff
Quick (9)] and counted. Quantitation of
the results is usually tedious, as cells
may not be clearly visible. Also, it is not
possible to assess invasion during the incubation period and count cells that have
started invading the gel but have not
reached the lower surface of the membrane. Numerous technical papers have
addressed these difficulties (2,7,9).
We have used a supra vital dye,
Hoechst 33342 (Sigma, St. Louis, MO,
USA) to stain cells during the invasion
assay. This is a vital fluorescent stain
that binds specifically to AT-rich nuclear DNA (1,3,10). It is excited by UV
rays and emits blue fluorescence.
In the preliminary experiments, cervical carcinoma (SiHa) cells pulse-labeled for 20 min with Hoechst 33342 at
2 µg/mL showed bright nuclear
fluorescence and did not exhibit any
toxicity on viability, proliferation, and
motility. These observations were comparable to earlier reports (6). The same
concentration was used in the subsequent experiments, performed in triplicate. The methodology used was as described previously (4), using 6.5-mm
transwell chambers with 8 µm pore size
(Corning Costar, Acton, MA, USA).
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